Travere Therapeutics, Inc. Common Stock (TVTX) News

Latest headlines that mention TVTX, newest first · each headline opens the original publisher

TVTX quote

Last price: $49.60
Day change: -6.04%
Next earnings: 2026-10-29

Quote & chart Expected move Insider trading IV rank history

TVTX headlines

last 30 days

Investing.com 14d ago

Travere to present FILSPARI data at ASN Kidney Week 2026

General T3TVTX

Investing.com 25d ago

Travere Therapeutics stock falls amid CEO transition news

General T3TVTX

Seeking Alpha 25d ago

Travere Therapeutics appoints Bradley Campbell as CEO, replacing Eric Dube

General T2TVTX

Investing.com 25d ago

Travere Therapeutics CEO Eric Dube to step down in December

General T3TVTX

Investing.com 28d ago

Travere therapeutics chief research officer William Rote sells $13.1m in stock

General T3TVTX

Investing.com 28d ago

Travere Therapeutics EVP Peter Heerma sells $17.8m in company stock

General T3TVTX

Investing.com 28d ago

Travere therapeutics CEO Eric Dube sells $25.4m in shares

General T3TVTX

Investing.com 28d ago

Travere Therapeutics CFO Cline sells $3.1m in company stock

General T3TVTX

Investing.com 28d ago

Travere Therapeutics SVP sells $335k in stock

General T3TVTX

TVTX news alerts

Get an alert by email or push when a new headline mentions TVTX.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.